Sunshine Biopharma Inc (SBFM)

0.0004 +0.00  +0.00% OTC Markets Dec 6, 20:00 Delayed 15m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
02/01/2019 Splits Ratio: 1:20
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.sunshinebiopharma.com
  • Investor Relations URL: N/A
  • HQ State/Province: Quebec
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: N/A
  • Last Earnings Release: N/A
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Sunshine Biopharma Inc is a pharmaceutical company operating in Canada. It focuses on the research, development, and commercialization of proprietary drugs for the treatment of various forms of cancer. The key product of the company is Adva-27a, a small molecule that destroys multidrug resistant cancer cells, including pancreatic cancer cells, small-cell lung cancer cells, breast cancer cells and uterine sarcoma cells. The company also sells several prescription generic drugs under its own brand SBI such as SBI-Anastrozole for treatment of Breast Cancer, SBI-Letrozole for treatment of Breast Cancer, SBI-Bicalutamide for treatment of Prostate Cancer and SBI-Finasteride for treatment of benign prostatic hyperplasia.

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.